The Plant-Based Company to Keep a Close Eye on in 2022
This may be the top plant-based dairy small cap company to watch going into the new year.
Continue Reading

PTPI Insider Trading (Petros Pharmaceuticals)

Insider Ownership Percentage: 9.70%
Insider Buying (Last 12 Months): $2,858,308.04
Insider Selling (Last 12 Months): $0.00

Petros Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Petros Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Petros Pharmaceuticals Share Price & Price History

Current Price: $2.09
Price Change: Price Increase of +0.26 (14.21%)
As of 11/26/2021 01:00 AM ET

This chart shows the closing price history over time for PTPI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Next Breakthrough Plant-Based Dairy Company
The growing demand for plant based dairy products may hurl this company to the spotlight.
Continue Reading

Petros Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/18/2021John D. ShulmanDirectorBuy1,661,807$1.72$2,858,308.04View SEC Filing Icon  
See Full Table
Insider Buying at Petros Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Petros Pharmaceuticals and related companies.

SEC Filings (Institutional Ownership Changes) for Petros Pharmaceuticals (NASDAQ:PTPI)

9.65% of Petros Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PTPI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Petros Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/12/2021NorthRock Partners LLC115,295$0.43M0.0%-47.4%1.173%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC14,364$45K0.0%N/A0.146%Search for SEC Filing on Google Icon
8/16/2021Shay Capital LLC238,764$0.75M0.1%-7.0%2.437%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC54,887$0.17M0.0%-70.4%0.560%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC23,725$74K0.0%+67.3%0.242%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.107,500$0.34M0.0%+21.2%1.097%Search for SEC Filing on Google Icon
8/12/2021NorthRock Partners LLC219,188$0.69M0.1%-35.1%2.237%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC100,000$0.31M0.2%+122.2%1.021%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners44,000$0.14M0.1%N/A0.449%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC35,492$0.13M0.0%N/A0.362%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC35,492$0.13M0.0%N/A0.363%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC185,545$0.69M0.0%+29.5%1.900%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC14,180$52K0.0%N/A0.145%Search for SEC Filing on Google Icon
5/11/2021NorthRock Partners LLC337,531$1.26M0.1%-12.3%3.455%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.18,277$68K0.0%+35.1%0.187%Search for SEC Filing on Google Icon
4/12/2021FNY Investment Advisers LLC20,000$73K0.0%N/A0.205%Search for SEC Filing on Google Icon
3/4/2021Neville Rodie & Shaw Inc.21,875$96K0.0%N/A0.224%Search for SEC Filing on Google Icon
2/16/2021One68 Global Capital LLC24,883$0.11M0.2%N/A0.255%Search for SEC Filing on Google Icon
2/11/2021Cannell Peter B & Co. Inc.25,484$0.11M0.0%N/A0.261%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC143,247$0.63M0.0%N/A1.466%Search for SEC Filing on Google Icon
2/8/2021NorthRock Partners LLC385,031$1.69M0.2%N/A3.942%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.13,531$59K0.0%N/A0.284%Search for SEC Filing on Google Icon
2/5/2021CM Management LLC45,000$0.20M0.2%N/A0.946%Search for SEC Filing on Google Icon
1/25/2021Acorn Financial Advisory Services Inc. ADV62,700$0.28M0.1%N/A1.318%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Petros Pharmaceuticals, Inc. engages in identifying, acquiring, developing, and commercializing therapeutics for men's health issues in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company develops H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. It also offers prescription medication, such as Stendra for the treatment of male erectile dysfunction; and vacuum erection devices. Petros Pharmaceuticals, Inc. is based in New York, New York.
Read More on Petros Pharmaceuticals

Today's Range

Now: $2.09
Low: $1.80
High: $2.33

50 Day Range

MA: $1.95
Low: $1.33
High: $2.88

52 Week Range

Now: $2.09
Low: $1.19
High: $5.96

Volume

6,959,600 shs

Average Volume

1,918,726 shs

Market Capitalization

$27.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.72

Who are the company insiders with the largest holdings of Petros Pharmaceuticals?

Petros Pharmaceuticals' top insider investors include:
  1. John D Shulman (Director)

Who are the major institutional investors of Petros Pharmaceuticals?

Petros Pharmaceuticals' top institutional shareholders include:
  1. NorthRock Partners LLC — 1.17%

Which institutional investors are selling Petros Pharmaceuticals stock?

Within the last quarter, PTPI stock was sold by these institutional investors:
  1. NorthRock Partners LLC
Could December 1st Be The Most Profitable Event in Crypto history?
Missed Out on Crypto Boom?
>>Watch This<<